Eun Jung Lee

USPTO Granted Patents = 25 (Patent Applications = 21)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Goyang, KR (2013)
Seoul, KR (2013 - 2024)

Company Filing History:

Korea University Research and Business Foundation

patents

4. 2 out of 2,164

Korea Institute of Science and Technology

Korea Food Research Institute

patents

7. 1 out of 19

Solus Advanced Materials Co., Ltd.

patents

8. 1 out of 1

Mcnulty Pharma Co., Ltd.

patent

9. 1 out of 1

Korea Mcnulty Co., Ltd.

Lotte Fine Chemical Co., Ltd.

Samsung Electronics Co., Ltd.

patents

Years Active: 2013-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. D1088019 - Display screen or portion thereof with transitional graphical user interface (2025-08-12),

2. D1067256 - Display screen or portion thereof with graphical user interface (2025-03-18),

3. D1063977 - Display screen or portion thereof with graphical user interface (2025-02-25),

4. D1063976 - Display screen or portion thereof with graphical user interface (2025-02-25),

5. D1063975 - Display screen or portion thereof with graphical user interface (2025-02-25),

6. D1063974 - Display screen or portion thereof with graphical user interface (2025-02-25),

7. 12076356 - Composition comprising Molokhia extract as active ingredient for improving gut microbiome or for alleviating, preventing, or treating intestinal inflammation, leaky gut syndrome, obesity, or metabolic disease (2024-09-03),

8. D1034670 - Display screen or portion thereof with graphical user interface (2024-07-09),

9. D1031757 - Display screen or portion thereof with graphical user interface (2024-06-18),

10. D1031755 - Display screen or portion thereof with graphical user interface (2024-06-18),

11. 11952412 - Exosome-based anticancer agent (2024-04-09),

12. 11456422 - Compound and organic electroluminescent device comprising same (2022-09-27),

13. 11319360 - Exosome-based anticancer agent (2022-05-03),

14. 11071807 - Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide (2021-07-27),

15. 11000048 - Method of producing protein-containing powder (2021-05-11),

Title: The Innovations of Eun Jung Lee: Enhancing Cancer Treatment and Illuminating Technology

Introduction:

Eun Jung Lee, a prolific inventor based in Seoul, South Korea, has made significant contributions to the fields of medicine and technology. With a total of 15 patents to his name, Lee's groundbreaking work has the potential to revolutionize cancer treatment and organic electronics.

Latest Patents:

1. Exosome-based anticancer agent: Lee's invention introduces a novel recombinant exosome with a phagocytosis-promoting protein on its surface, offering new possibilities for anticancer therapy.

2. Compound and organic electroluminescent device: Lee's innovative compound enhances the performance of organic electroluminescent devices, improving characteristics such as light-emitting efficiency and service life.

Career Highlights:

Throughout his career, Lee has been associated with esteemed organizations such as Doosan Corporation and Korea University Research and Business Foundation. These experiences have provided him with the resources and expertise to pursue groundbreaking innovations.

Collaborations:

Lee has collaborated with talented individuals such as Yoo Soo Yang and Tae Hyung Kim, synergizing their skills and expertise to push the boundaries of scientific research and technological advancement.

Conclusion:

Eun Jung Lee's relentless pursuit of innovation has led to groundbreaking advancements in cancer treatment and organic electronics. His patents stand as a testament to his ingenuity and dedication to improving the world through cutting-edge technologies.

This text is generated by artificial intelligence and may not be accurate.